TALLAHASSEE The Florida Department of Health (DOH) is working closely with state and local partners to continue investigating reported cases of E. coli O157:H7 and/or Hemolytic Uremic Syndrome (HUS) in central Florida. As of March 30, 2005, there have been 19 cases confirmed cases in children and three confirmed cases in adults, as well as
15 suspected cases in children and nine suspected cases in adults.
A suspected case involves individuals with diarrhea with variable severity (from mild to severe and bloody) who have recently attended Florida fairs or festivals, while a confirmed case involves individuals with diarrhea with variable severity (from mild to severe and bloody) that has tested positive for E. coli O157:H7 and/or a diagnosis of HUS, and has recently attended Florida fairs or festivals.
If you or your children attended a recent event with animal exhibits, and has diarrhea with variable severity (from mild to severe and bloody), contact your healthcare provider.
To avoid infection and illness, DOH recommends the following safety tips:
Wash hands often, and immediately after contact with domestic or farm animals.
Do not eat undercooked meat.
If you suspect your child may have symptoms of infection, contact your health care provider.
Source: Florida Department of Health
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.